Skip to main content

Regulatory Toxicology and Pharmacology

  • ISSN: 0273-2300

Next planned ship date: May 13, 2024

  • 5 Year impact factor: 3.6
  • Impact factor: 3.4

Regulatory Toxicology and Pharmacology publishes peer reviewed articles that involve the generation, evaluation, and interpretation of experimental animal and human data that… Read more

Subscription options

Next planned ship date:
May 13, 2024

Institutional subscription on ScienceDirect

Request a sales quote
Regulatory Toxicology and Pharmacology publishes peer reviewed articles that involve the generation, evaluation, and interpretation of experimental animal and human data that are of direct importance and relevance for regulatory authorities with respect to toxicological and pharmacological regulations in society. All peer-reviewed articles that are published should be devoted to improve the protection of human health and environment. Reviews and discussions are welcomed that address legal and/or regulatory decisions with respect to risk assessment and management of toxicological and pharmacological compounds on a scientific basis. It addresses an international readership of scientists, risk assessors and managers, and other professionals active in the field of human and environmental health.

Types of peer-reviewed articles published:

Original research articles of relevance for regulatory aspects covering aspects including, but not limited to:

Factors influencing human sensitivity

Exposure science related to risk assessment

Alternative toxicological test methods

Frameworks for evaluation and integration of data in regulatory evaluations

Harmonization across regulatory agencies

Read-across methods and evaluations

Contemporary Reviews on policy related Research issues

Letters to the Editor

Guest Editorials (by Invitation)



News on recent or upcoming policy related Research issues, outcomes of regulatory expert meetings with implications for risk assessment and management

RTP Tobacco policy

Regulatory Toxicology and Pharmacology, as the journal serving developments for improvement of human health and environment, will not consider manuscripts that have been supported by tobacco companies.